For example, it is known that systemic adiponectin abnormalities predicted a favourable response to ketamine in patients with major depressive disorder, a finding echoed in studies of SSRI- and SNRI-treated individuals. The gene discussed is ADIPOQ; the disease is major depressive disorder.